The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
Open accessAbstract
Esophageal cancer is the sixth leading cause of cancer-related deaths worldwide. Squamous cell carcinoma is the most common histology in Eastern Europe and Asia, and adenocarcinoma is most common in North America and Western Europe. Surgery is a major component of treatment of locally advanced resectable esophageal and esophagogastric junction (EGJ) cancer, and randomized trials have shown that the addition of preoperative chemoradiation or perioperative chemotherapy to surgery significantly improves survival. Targeted therapies including trastuzumab, ramucirumab, and pembrolizumab have produced encouraging results in the treatment of patients with advanced or metastatic disease. Multidisciplinary team management is essential for all patients with esophageal and EGJ cancers. This selection from the NCCN Guidelines for Esophageal and Esophagogastric Junction Cancers focuses on recommendations for the management of locally advanced and metastatic adenocarcinoma of the esophagus and EGJ.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
Toxicity and response criteria of the Eastern Cooperative Oncology Group
Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T., & Carbone, P. P. (1982) · AMERICAN JOURNAL OF CLINICAL ONCOLOGY · doi:10.1097/00000421-198212000-00014 · Cited by 11,647
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Bang, Y.-J., Van Cutsem, E., Feyereislova, A., Chung, H. C., Shen, L., Sawaki, A., Lordick, F., Ohtsu, A., Omuro, Y., Satoh, T., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61121-x · Cited by 7,302
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Le, D. T., Durham, J. N., Smith, K. N., Wang, H., Bartlett, B. R., Aulakh, L. K., Lu, S., Kemberling, H., Wilt, C., Luber, B. S., et al. (2017) · Science · doi:10.1126/science.aan6733 · Cited by 6,645
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
Cunningham, D., Allum, W. H., Stenning, S. P., Thompson, J. N., Van de Velde, C. J. H., Nicolson, M., Scarffe, J. H., Lofts, F. J., Falk, S. J., Iveson, T. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055531 · Cited by 6,334
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
van Hagen, P., Hulshof, M. C. C. M., van Lanschot, J. J. B., Steyerberg, E. W., Henegouwen, M. I. V. B., Wijnhoven, B. P. L., Richel, D. J., Nieuwenhuijzen, G. A. P., Hospers, G. A. P., Bonenkamp, J. J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112088 · Cited by 5,521
Global Cancer Incidence and Mortality Rates and Trends—An Update
Torre, L. A., Siegel, R. L., Ward, E. M., & Jemal, A. (2016) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0578 · Cited by 3,692
Macdonald, J. S., Smalley, S. R., Benedetti, J., Hundahl, S. A., Estes, N. C., Stemmermann, G. N., Haller, D. G., Ajani, J. A., Gunderson, L. L., Jessup, J. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010187 · Cited by 3,475
Self-citationThe clinical evaluation of chemotherapeutic agents in cancer
Karnofsky, D. A. (1949) · Medical Entomology and Zoology · Cited by 2,933
Al-Batran, S.-E., Homann, N., Pauligk, C., Goetze, T. O., Meiler, J., Kasper, S., Kopp, H.-G., Mayer, F., Haag, G. M., Luley, K., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32557-1 · Cited by 2,648
Shapiro, J., van Lanschot, J. J. B., Hulshof, M. C. C. M., van Hagen, P., van Berge Henegouwen, M. I., Wijnhoven, B. P. L., van Laarhoven, H. W. M., Nieuwenhuijzen, G. A. P., Hospers, G. A. P., Bonenkamp, J. J., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00040-6 · Cited by 2,565
Wilke, H., Muro, K., Van Cutsem, E., Oh, S.-C., Bodoky, G., Shimada, Y., Hironaka, S., Sugimoto, N., Lipatov, O., Kim, T.-Y., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70420-6 · Cited by 2,438
Self-citationCapecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
Cunningham, D., Starling, N., Rao, S., Iveson, T., Nicolson, M., Coxon, F., Middleton, G., Daniel, F., Oates, J., & Norman, A. R. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa073149 · Cited by 2,285
Fuchs, C. S., Tomasek, J., Yong, C. J., Dumitru, F., Passalacqua, R., Goswami, C., Safran, H., dos Santos, L. V., Aprile, G., Ferry, D. R., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61719-5 · Cited by 2,188
Herskovic, A., Martz, K., Al-Sarraf, M., Leichman, L., Brindle, J., Vaitkevicius, V., Cooper, J., Byhardt, R., Davis, L., & Emami, B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206113262403 · Cited by 2,108
Ychou, M., Boige, V., Pignon, J.-P., Conroy, T., Bouché, O., Lebreton, G., Ducourtieux, M., Bedenne, L., Fabre, J.-M., Saint-Aubert, B., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.0597 · Cited by 2,086
Cooper, J. S., Guo, M. D., Herskovic, A., Macdonald, J. S., Martenson, Jr., Al-Sarraf, M., Byhardt, R., Russell, A. H., Beitler, J. J., Spencer, S., et al. (1999) · JAMA · doi:10.1001/jama.281.17.1623 · Cited by 1,957
Van Cutsem, E., Moiseyenko, V. M., Tjulandin, S., Majlis, A., Constenla, M., Boni, C., Rodrigues, A., Fodor, M., Chao, Y., Voznyi, E., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.8429 · Cited by 1,926
Self-citationFuchs, C. S., Doi, T., Jang, R. W., Muro, K., Satoh, T., Machado, M., Sun, W., Jalal, S. I., Shah, M. A., Metges, J.-P., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.0013 · Cited by 1,784
Self-citationBang, Y.-J., Kim, Y.-W., Yang, H.-K., Chung, H. C., Park, Y.-K., Lee, K. H., Lee, K.-W., Kim, Y. H., Noh, S.-I., Cho, J. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61873-4 · Cited by 1,705
Sjoquist, K. M., Burmeister, B. H., Smithers, B. M., Zalcberg, J. R., Simes, R. J., Barbour, A., & Gebski, V. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70142-5 · Cited by 1,647
Minsky, B. D., Pajak, T. F., Ginsberg, R. J., Pisansky, T. M., Martenson, J. A., Komaki, R. U., Okawara, G. S., Rosenthal, S. A., & Kelsen, D. P. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1167 · Cited by 1,615
Karnofsky performance status revisited: reliability, validity, and guidelines.
Schag, C. C., Heinrich, R. L., & Ganz, P. A. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.3.187 · Cited by 1,517
Tepper, J., Krasna, M. J., Niedzwiecki, D., Hollis, D., Reed, C. E., Goldberg, R., Kiel, K., Willett, C., Sugarbaker, D., & Mayer, R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.9593 · Cited by 1,352
Self-citationShitara, K., Özgüroğlu, M., Bang, Y.-J., Di Bartolomeo, M., Mandalà, M., Ryu, M.-H., Fornaro, L., Olesiński, T., Caglevic, C., Chung, H. C., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31257-1 · Cited by 1,296
Bedenne, L., Michel, P., Bouché, O., Milan, C., Mariette, C., Conroy, T., Pezet, D., Roullet, B., Seitz, J.-F., Herr, J.-P., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7118 · Cited by 1,244
Assessment of a HER2 scoring system for gastric cancer: results from a validation study
Hofmann, M., Stoss, O., Shi, D., Büttner, R., Van De Vijver, M., Kim, W., Ochiai, A., Rüschoff, J., & Henkel, T. (2008) · Histopathology · doi:10.1111/j.1365-2559.2008.03028.x · Cited by 1,187
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
Gravalos, C., & Jimeno, A. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn169 · Cited by 1,184
Muro, K., Chung, H. C., Shankaran, V., Geva, R., Catenacci, D., Gupta, S., Eder, J. P., Golan, T., Le, D. T., Burtness, B., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)00175-3 · Cited by 1,121
Noh, S. H., Park, S. R., Yang, H.-K., Chung, H. C., Chung, I.-J., Kim, S.-W., Kim, H.-H., Choi, J.-H., Kim, H.-K., Yu, W., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70473-5 · Cited by 1,049
Allum, W. H., Stenning, S. P., Bancewicz, J., Clark, P. I., & Langley, R. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.2083 · Cited by 989
Smalley, S. R., Benedetti, J. K., Haller, D. G., Hundahl, S. A., Estes, N. C., Ajani, J. A., Gunderson, L. L., Goldman, B., Martenson, J. A., Jessup, J. M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.7136 · Cited by 842
Self-citationAl-Batran, S.-E., Hartmann, J. T., Probst, S., Schmalenberg, H., Hollerbach, S., Hofheinz, R., Rethwisch, V., Seipelt, G., Homann, N., Wilhelm, G., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9378 · Cited by 782
Population Attributable Risks of Esophageal and Gastric Cancers
Engel, L. S., Chow, W.-H., Vaughan, T. L., Gammon, M. D., Risch, H. A., Stanford, J. L., Schoenberg, J. B., Mayne, S. T., Dubrow, R., Rotterdam, H., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg047 · Cited by 775
Kang, Y.-K., Kang, W.-K., Shin, D.-B., Chen, J., Xiong, J., Wang, J., Lichinitser, M., Guan, Z., Khasanov, R., Zheng, L., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn717 · Cited by 764
Urschel, J. D., & Vasan, H. (2003) · The American Journal of Surgery · doi:10.1016/s0002-9610(03)00066-7 · Cited by 737
Tanner, M., Hollmén, M., Junttila, T. T., Kapanen, A. I., Tommola, S., Soini, Y., Helin, H., Salo, J., Joensuu, H., Sihvo, E., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi064 · Cited by 665
Rüdiger Siewert, J., Feith, M., Werner, M., & Stein, H. J. (2000) · Annals of Surgery · doi:10.1097/00000658-200009000-00007 · Cited by 662
Thuss-Patience, P. C., Kretzschmar, A., Bichev, D., Deist, T., Hinke, A., Breithaupt, K., Dogan, Y., Gebauer, B., Schumacher, G., & Reichardt, P. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.06.002 · Cited by 612
Ford, H. E. R., Marshall, A., Bridgewater, J. A., Janowitz, T., Coxon, F. Y., Wadsley, J., Mansoor, W., Fyfe, D., Madhusudan, S., Middleton, G. W., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70549-7 · Cited by 595
Hironaka, S., Ueda, S., Yasui, H., Nishina, T., Tsuda, M., Tsumura, T., Sugimoto, N., Shimodaira, H., Tokunaga, S., Moriwaki, T., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.5805 · Cited by 541
Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis
Fiorica, F., Di Bona, D., Schepis, F., Licata, A., Shahied, L., Venturi, A., Falchi, A. M., Craxì, A., & Cammà, C. (2004) · Gut · doi:10.1136/gut.2003.025080 · Cited by 539
Shitara, K., Doi, T., Dvorkin, M., Mansoor, W., Arkenau, H.-T., Prokharau, A., Alsina, M., Ghidini, M., Faustino, C., Gorbunova, V., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30739-3 · Cited by 511
Self-citationOppedijk, V., van der Gaast, A., van Lanschot, J. J. B., van Hagen, P., van Os, R., van Rij, C. M., van der Sangen, M. J., Beukema, J. C., Rütten, H., Spruit, P. H., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.2186 · Cited by 502
Shah, M. A., Kojima, T., Hochhauser, D., Enzinger, P., Raimbourg, J., Hollebecque, A., Lordick, F., Kim, S.-B., Tajika, M., Kim, H. T., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.5441 · Cited by 496
Self-citationRüschoff, J., Dietel, M., Baretton, G., Arbogast, S., Walch, A., Monges, G., Chenard, M.-P., Penault-Llorca, F., Nagelmeier, I., Schlake, W., et al. (2010) · Virchows Archiv · doi:10.1007/s00428-010-0952-2 · Cited by 486
Ross, P., Nicolson, M., Cunningham, D., Valle, J., Seymour, M., Harper, P., Price, T., Anderson, H., Iveson, T., Hickish, T., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.105 · Cited by 475
Optimum Lymphadenectomy for Esophageal Cancer
Rizk, N. P., Ishwaran, H., Rice, T. W., Chen, L.-Q., Schipper, P. H., Kesler, K. A., Law, S., Lerut, T. E. M. R., Reed, C. E., Salo, J. A., et al. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181b2f6ee · Cited by 461
Self-citationBartley, A. N., Washington, M. K., Colasacco, C., Ventura, C. B., Ismaila, N., Benson, A. B., Carrato, A., Gulley, M. L., Jain, D., Kakar, S., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.4836 · Cited by 458
Self-citationConroy, T., Galais, M.-P., Raoul, J.-L., Bouché, O., Gourgou-Bourgade, S., Douillard, J.-Y., Etienne, P.-L., Boige, V., Martel-Lafay, I., Michel, P., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70028-2 · Cited by 449
Ohtsu, A., Shimada, Y., Shirao, K., Boku, N., Hyodo, I., Saito, H., Yamamichi, N., Miyata, Y., Ikeda, N., Yamamoto, S., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.130 · Cited by 427
A Prospective Study of Tobacco, Alcohol, and the Risk of Esophageal and Gastric Cancer Subtypes
Freedman, N. D., Abnet, C. C., Leitzmann, M. F., Mouw, T., Subar, A. F., Hollenbeck, A. R., & Schatzkin, A. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm051 · Cited by 421
Ajani, J. A., Winter, K., Okawara, G. S., Donohue, J. H., Pisters, P. W. T., Crane, C. H., Greskovich, J. F., Anne, P. R., Bradley, J. D., Willett, C., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.4840 · Cited by 385
Self-citationvan Westreenen, H. L., Westerterp, M., Bossuyt, P. M. M., Pruim, J., Sloof, G. W., van Lanschot, J. J. B., Groen, H., & Plukker, J. T. M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.083 · Cited by 370
Dank, M., Zaluski, J., Barone, C., Valvere, V., Yalcin, S., Peschel, C., Wenczl, M., Goker, E., Cisar, L., Wang, K., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn166 · Cited by 343
Lagergren, J., Bergström, R., Lindgren, A., & Nyrén, O. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000201)85:3<340::aid-ijc8>3.0.co;2-n · Cited by 337
Doi, T., Piha-Paul, S. A., Jalal, S. I., Saraf, S., Lunceford, J., Koshiji, M., & Bennouna, J. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.9846 · Cited by 318
Fuchs, C. S., Moore, M. R., Harker, G., Villa, L., Rinaldi, D., & Hecht, J. R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.058 · Cited by 296
Fuchs, C. S., Shitara, K., Di Bartolomeo, M., Lonardi, S., Al-Batran, S.-E., Van Cutsem, E., Ilson, D. H., Alsina, M., Chau, I., Lacy, J., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30791-5 · Cited by 288
Self-citationMurphy, K. M., Zhang, S., Geiger, T., Hafez, M. J., Bacher, J., Berg, K. D., & Eshleman, J. R. (2006) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2006.050092 · Cited by 281
Activity of Taxol in Patients With Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus
Ajani, J. A., Ilson, D. H., Daugherty, K., Pazdur, R., Lynch, P. M., & Kelsen, D. P. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.14.1086 · Cited by 280
Self-citationBouché, O., Raoul, J. L., Bonnetain, F., Giovannini, M., Etienne, P. L., Lledo, G., Arsène, D., Paitel, J. F., Guérin-Meyer, V., Mitry, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.140 · Cited by 274
Guimbaud, R., Louvet, C., Ries, P., Ychou, M., Maillard, E., André, T., Gornet, J.-M., Aparicio, T., Nguyen, S., Azzedine, A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.1011 · Cited by 263
Okines, A. F. C., Norman, A. R., McCloud, P., Kang, Y.-K., & Cunningham, D. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp047 · Cited by 258
Lorenzen, S., Schuster, T., Porschen, R., Al-Batran, S.-E., Hofheinz, R., Thuss-Patience, P., Moehler, M., Grabowski, P., Arnold, D., Greten, T., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp069 · Cited by 241
Alderson, D., Cunningham, D., Nankivell, M., Blazeby, J. M., Griffin, S. M., Crellin, A., Grabsch, H. I., Langer, R., Pritchard, S., Okines, A., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30447-3 · Cited by 225
Steyerberg, E. W., Neville, B. A., Koppert, L. B., Lemmens, V. E. P. P., Tilanus, H. W., Coebergh, J.-W. W., Weeks, J. C., & Earle, C. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.0658 · Cited by 222
A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma
Turati, F., Tramacere, I., La Vecchia, C., & Negri, E. (2013) · Annals of Oncology · doi:10.1093/annonc/mds244 · Cited by 209
Kojima, T., Muro, K., Francois, E., Hsu, C.-H., Moriwaki, T., Kim, S.-B., Lee, S.-H., Bennouna, J., Kato, K., Lin, S., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.2019.37.4_suppl.2 · Cited by 202
Self-citationShah, M. A., Janjigian, Y. Y., Stoller, R., Shibata, S., Kemeny, M., Krishnamurthi, S., Su, Y. B., Ocean, A., Capanu, M., Mehrotra, B., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.60.7465 · Cited by 178
Boonstra, J. J., Kok, T. C., Wijnhoven, B. P., van Heijl, M., van Berge Henegouwen, M. I., ten Kate, F. J., Siersema, P. D., Dinjens, W. N., van Lanschot, J. J., Tilanus, H. W., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-181 · Cited by 174
Kato, K., Shah, M. A., Enzinger, P., Bennouna, J., Shen, L., Adenis, A., Sun, J.-M., Cho, B. C., Özgüroğlu, M., Kojima, T., et al. (2019) · Future Oncology · doi:10.2217/fon-2018-0609 · Cited by 171
Self-citationChemoradiation in the Management of Esophageal Cancer
Kleinberg, L., & Forastiere, A. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.0881 · Cited by 161
Self-citationObesity, metabolic syndrome and esophageal adenocarcinoma: Epidemiology, etiology and new targets
Ryan, A. M., Duong, M. T., Healy, L., Ryan, S. A., Parekh, N., Reynolds, J. V., & Power, D. G. (2011) · Cancer Epidemiology · doi:10.1016/j.canep.2011.03.001 · Cited by 151
Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer
Janmaat, V. T., Steyerberg, E. W., van der Gaast, A., Mathijssen, R. H. J., Bruno, M. J., Peppelenbosch, M. P., Kuipers, E. J., & Spaander, M. C. W. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004063.pub4 · Cited by 150
Sumpter, K., Harper-Wynne, C. L., Cunningham, D., Rao, S., Tebbutt, N. C., Norman, A. R., Ward, C., Iveson, T. J., Nicolson, M. C., Hickish, T., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602572 · Cited by 147
Assersohn, L., Brown, G. M., Cunningham, D., Ward, C., Oates, J. R., Waters, J. S., Hill, M. E., & Norman, A. R. (2003) · Annals of Oncology · doi:10.1093/annonc/mdh007 · Cited by 147
Kim, G. M., Jeung, H., Rha, S. Y., Kim, H. S., Jung, I., Nam, B., Lee, K. H., & Chung, H. C. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.12.017 · Cited by 140
A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus.
Ilson, D. H., Forastiere, A. A., Arquette, M. A., Costa, F., Heelan, R. T., Huang, Y., & Kelsen, D. P. (2000) · PubMed · Cited by 135
Self-citationKato, S., Okamura, R., Baumgartner, J. M., Patel, H., Leichman, L., Kelly, K. J., Sicklick, J. K., Fanta, P. T., Lippman, S. M., & Kurzrock, R. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1128 · Cited by 130
Self-citationNoordman, B. J., Verdam, M. G. E., Lagarde, S. M., Hulshof, M. C. C. M., van Hagen, P., Henegouwen, M. I. V. B., Wijnhoven, B. P. L., van Laarhoven, H. W. M., Nieuwenhuijzen, G. A. P., Hospers, G. A. P., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.7718 · Cited by 127
Khushalani, N. I., Leichman, C. G., Proulx, G. M., Nava, H., Bodnar, L. M., Klippenstein, D. L., Litwin, A. M., Smith, J. L., Nava, M. E. R., Pendyala, L., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.032 · Cited by 116
Enzinger, P. C., Burtness, B. A., Niedzwiecki, D., Ye, X., Douglas, K., Ilson, D. H., Villaflor, V. M., Cohen, S. J., Mayer, R. J., Venook, A. P., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.5092 · Cited by 112
Self-citationPaclitaxel given by a weekly 1-h infusion in advanced esophageal cancer
Ilson, D. H., Wadleigh, R. G., Leichman, L., & Kelsen, D. P. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm004 · Cited by 100
Self-citationSudo, K., Taketa, T., Correa, A. M., Campagna, M.-C., Wadhwa, R., Blum, M. A., Komaki, R. U., Lee, J. H., Bhutani, M. S., Weston, B. R., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.7250 · Cited by 81
Self-citationSym, S. J., Hong, J., Park, J., Cho, E. K., Lee, J. H., Park, Y. H., Lee, W. K., Chung, M., Kim, H.-S., Park, S. H., et al. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-2027-3 · Cited by 80
Bang, Y., Muro, K., Fuchs, C. S., Golan, T., Geva, R., Hara, H., Jalal, S. I., Borg, C., Doi, T., Wainberg, Z. A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.4012 · Cited by 73
Park, Y. H., Lee, J., Ryoo, B., Ryu, M., Yang, S. H., Kim, B. S., Shin, D. B., Chang, H. M., Kim, T. W., Yuh, Y. J., et al. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0515-7 · Cited by 70
Zhao, X., Ren, Y., Hu, Y., Cui, N., Wang, X., & Cui, Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202185 · Cited by 66
PD-1 blockade in mismatch repair deficient non-colorectal gastrointestinal cancers.
Le, D. T., Uram, J. N., Wang, H., Kemberling, H., Eyring, A. D., Bartlett, B. R., Goldberg, R. M., Crocenzi, T. S., Fisher, G. A., Lee, J. J., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.4_suppl.195 · Cited by 64
Iyer, R. B., Wilkinson, N. W., Demmy, T. L., & Javle, M. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.10.026 · Cited by 61
Improved Long-Term Outcome With Chemoradiotherapy Strategies in Esophageal Cancer
Swisher, S. G., Hofstetter, W. L., Komaki, R. U., Correa, A. M., Erasmus, J., Lee, J. H., Liao, Z. X., Maru, D. M., Mehran, R. J., Patel, S., et al. (2010) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2010.04.061 · Cited by 58
Self-citationSoularue, É., Cohen, R., Tournigand, C., Zaanan, A., Louvet, C., Bachet, J., Hentic, O., Samalin, E., Chibaudel, B., de Gramont, A., et al. (2015) · Bulletin du Cancer · doi:10.1016/j.bulcan.2014.08.001 · Cited by 57
Munden, R. F., Macapinlac, H. A., & Erasmus, J. J. (2006) · Journal of Thoracic Imaging · doi:10.1097/00005382-200605000-00005 · Cited by 54
Moehler, M. H., Kanzler, S., Geißler, M., Raedle, J., Ebert, M., Daum, S., Flieger, D., Seufferlein, T. T. W., Galle, P. R., & Hoehler, T. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp269 · Cited by 54
Bando, H., Doi, T., Muro, K., Yasui, H., Nishina, T., Yamaguchi, K., Takahashi, S., Nomura, S., Kuno, H., Shitara, K., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.04.009 · Cited by 49
Tabernero, J. M., Ohtsu, A., Muro, K., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0895 · Cited by 48
Sym, S. J., Ryu, M., Lee, J., Chang, H. M., Kim, T. W., Lee, S. S., Lee, J. S., & Kang, Y. (2008) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e31815878a2 · Cited by 38
Daniel, V. C., Wainberg, Z. A., Charles, S. F., Marcelo Garrido, S., Bang, Y., Muro, K., Savage, M. J., Wang, J., Koshiji, M., Rita, P. D., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx302.008 · Cited by 24
Lustberg, M. B., Bekaii‐Saab, T., Young, D., Otterson, G. A., Burak, W. E., Abbas, A., McCracken-Bussa, B., Lustberg, M. E., & Villalona-Calero, M. A. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d7776d · Cited by 16
Cited by
Shitara, K., Van Cutsem, E., Bang, Y.-J., Fuchs, C., Wyrwicz, L., Lee, K.-W., Kudaba, I., Garrido, M., Chung, H. C., Lee, J., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.3370 · Cited by 1,141
Self-citationLuo, H., Lu, J., Bai, Y., Mao, T., Wang, J., Fan, Q., Zhang, Y., Zhao, K., Chen, Z., Gao, S., et al. (2021) · JAMA · doi:10.1001/jama.2021.12836 · Cited by 803
Wang, Z.-X., Cui, C., Yao, J., Zhang, Y., Li, M., Feng, J., Yang, S., Fan, Y., Shi, J., Zhang, X., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.02.007 · Cited by 546
Piha‐Paul, S. A., Oh, D., Ueno, M., Malka, D., Chung, H. C., Nagrial, A., Kelley, R. K., Ros, W., Italiano, A., Nakagawa, K., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33013 · Cited by 486
Lu, Z., Wang, J., Shu, Y., Liu, L., Kong, L., Yang, L., Wang, B., Sun, G., Ji, Y., Cao, G., et al. (2022) · BMJ · doi:10.1136/bmj-2021-068714 · Cited by 485
Metadata
- Authors
- Ajani, J. A., D’Amico, T. A., Bentrem, D. J., Chao, J., Corvera, C., Das, P., Denlinger, C. S., Enzinger, P. C., Fanta, P., Farjah, F., Gerdes, H., Gibson, M., Glasgow, R. E., Hayman, J. A., Hochwald, S., Hofstetter, W. L., Ilson, D. H., Jaroszewski, D., Johung, K. L., Keswani, R. N., Kleinberg, L. R., Leong, S., Ly, Q. P., Matkowskyj, K. A., McNamara, M., Mulcahy, M. F., Paluri, R. K., Park, H., Perry, K. A., Pimiento, J., Poultsides, G. A., Roses, R., Strong, V. E., Wiesner, G., Willett, C. G., Wright, C. D., McMillian, N. R., & Pluchino, L. A.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2019-07
- Volume
- 17
- Issue
- 7
- Pages
- 855-883
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W2957409472
- Cited by
- 1,059
- References
- 103
- FWCI
- 130.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.